HBT(HBT)
HBT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $312M | $332M |
| Low | $310M | $327M |
| High | $314M | $337M |
| EBITDA Avg | $126M | $134M |
| Low | $125M | $132M |
| High | $126M | $136M |
| EBIT Avg | $119M | $127M |
| Low | $118M | $125M |
| High | $120M | $129M |
| Net Income Avg | $94M | $97M |
| Low | $91M | $95M |
| High | $94M | $100M |
| EPS Avg | $2.94 | $3.08 |
| Low | $2.89 | $3.01 |
| High | $2.99 | $3.19 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $81M | $82M | $81M | $82M | $83M | $85M |
| Low | $81M | $81M | $80M | $82M | $82M | $84M |
| High | $82M | $83M | $82M | $83M | $84M | $86M |
| EBITDA Avg | $33M | $33M | $33M | $33M | $34M | $34M |
| Low | $33M | $33M | $32M | $33M | $33M | $34M |
| High | $33M | $33M | $33M | $34M | $34M | $35M |
| EBIT Avg | $31M | $31M | $31M | $31M | $32M | $32M |
| Low | $31M | $31M | $31M | $31M | $31M | $32M |
| High | $31M | $32M | $31M | $32M | $32M | $33M |
| Net Income Avg | $25M | $26M | $24M | $25M | $26M | $27M |
| Low | $25M | $25M | $24M | $25M | $25M | $26M |
| High | $25M | $26M | $25M | $26M | $26M | $27M |
| EPS Avg | $0.75 | $0.77 | $0.73 | $0.76 | $0.77 | $0.80 |
| Low | $0.74 | $0.76 | $0.72 | $0.75 | $0.76 | $0.79 |
| High | $0.76 | $0.78 | $0.74 | $0.77 | $0.78 | $0.81 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |